News zum Sektor Gesundheit aus Australien & Ozeanien

 

New contract wins and a positive take on AI are tailwinds for this company. The post How much higher could Pro Medicus shares go? 2 brokers weigh in appeared first on The Motley Fool Australia....

LOS ANGELES, June 3, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Immutep Limited ("Immutep" or "the Company") (NASDAQ: IMMP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by......

With more than seven million daily users on the HotCopper forums, each…...

Things went from bad to worse for this fallen giant last month. The post Why did CSL shares crash 22% in May? appeared first on The Motley Fool Australia....

These shares are having a tough time on hump day. Let's find out why. The post Why Catapult Sports, Harvey Norman, Inghams, and Opthea shares are sinking today appeared first on The Motley Fool Australia....

As Syntara (ASX:SNT) advances a diversified clinical pipeline through 2026, investors are…...

Pro Medicus shares are down on AI fears. Here's why AI is actually making the company a once-in-a-generation buy opportunity. The post Why AI is making Pro Medicus shares a once-in-a-generation buy appeared first on The Motley Fool Australia....

Why it could be an ideal time to buy the dip on this exciting stock. The post Why 4DMedical shares can return to record highs: Expert appeared first on The Motley Fool Australia....

MELBOURNE, Australia and INDIANAPOLIS and HOUSTON, June 02, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) and United Imaging Healthcare North America, Inc. (“United Imaging”) today announce the signing of a Memorandum of Understanding (MOU) to evaluate a strategic research collaboration in the United States (U.S.) focused on advancing integrated theranostics solutions....

With more than seven million daily users on the HotCopper forums, each…...

These ASX healthcare shares may not regain investor confidence overnight, but I think they are worth studying while sentiment is weak. The post Are CSL and ResMed shares buys at 52-week lows? appeared first on The Motley Fool Australia....

It looks like brokers have lost confidence in one of these shares. The post WiseTech, Cochlear, CSL shares: Can these beaten down stocks rebound in 2026? appeared first on The Motley Fool Australia....

These shares are avoiding the market weakness and charging higher on Tuesday. The post Why DroneShield, Pro Medicus, SRG Global, and Woodside shares are charging higher today appeared first on The Motley Fool Australia....

The health technology company is targeting a large new market. The post Why are 4DMedical shares charging higher today? appeared first on The Motley Fool Australia....

MELBOURNE, Australia and INDIANAPOLIS, June 02, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") announces the oral presentation of Part 1 safety, dosimetry and pharmacokinetics data from the ProstACT Global Phase 3 Study of TLX591-Tx (lutetium-177 (177Lu) rosopatamab tetraxetan), in metastatic castration-resistant prostate cancer (mCRPC). The late-breaking data were presented today at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois by study Principal Investigator Pedro C. Barata, MD, Medical Oncologist, University Hospitals Seidman Cancer Center and Associate Professor of Medicine, Case Western Reserve University of School of Medicine, Cleveland, Ohio....

Acquisition adds Nidra® Tonic Motor Activation (TOMAC) Therapy, an FDA De Novo classified, nonpharmacologic treatment designed to address moderate-to-severe Restless Legs Syndrome (RLS). Acquisition adds Nidra® Tonic Motor Activation (TOMAC) Therapy, an FDA De Novo classified, nonpharmacologic treatment designed to address moderate-to-severe Restless Legs Syndrome (RLS)....

Short sellers are targeting WiseTech, Cochlear, and Lendlease shares. Here is whether the bears have a compelling case for each. The post Short sellers are targeting these 3 ASX shares this week. Are they right? appeared first on The Motley Fool Australia....

LOS ANGELES, June 1, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Immutep Limited ("Immutep" or "the Company") (NASDAQ: IMMP) for violations of §§10(b) and 20(a) of the Securities Exchange Act......

Health imaging company Pro Medicus (ASX:PME) has announced the signing of $44…...

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...